Xetra
10.09.26 | 17:35
236,20 Euro
+0,17 % +0,40
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 232,80 | 233,30 | 20:40 | |
| 232,70 | 233,30 | 20:40 |
► 10.09.: | | | | | | |
| |
► 09.09.: | | | | | | | | |
► Aktueller STRYKER Börsenkurs + Xetra-Orderbuch
► 09.09.: | | | | | | | | |
► Aktueller STRYKER Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 238,80 | 310 | |||
| 237,60 | 310 | |||
| 237,10 | 4 | |||
| 236,90 | 4 | |||
| 236,70 | 39 | |||
| 236,40 | 310 | |||
| 235,20 | 310 | |||
| 233,40 | 92 | |||
| 233,30 | 60 | |||
| 233,20 | 24 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/syk.htm [/URL] | ||||
| 9 | 233,00 | |||
| 84 | 232,60 | |||
| 54 | 232,40 | |||
| 310 | 231,60 | |||
| 339 | 230,40 | |||
| 10 | 230,00 | |||
| 310 | 229,20 | |||
| 10 | 229,00 | |||
| 4 | 228,80 | |||
| 4 | 228,60 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.134 | 1,290 | 1.463 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 16:25:28 | 238,90 | 2 |
| 16:22:48 | 238,50 | 30 |
| 16:00:05 | 235,80 | 25 |
| 15:21:33 | 237,00 | 50 |
| 12:08:52 | 238,40 | 77 |
| 12:08:52 | 238,40 | 73 |
| 11:41:45 | 239,00 | 27 |
| 11:06:40 | 239,00 | 30 |
| 11:06:40 | 238,80 | 100 |
| 11:06:40 | 238,70 | 70 |
| Tagesumsatz Xetra | +0,40 +0,17 % | 802 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Stryker To Acquire ZuriMED To Expand Shoulder And Rotator Cuff Portfolio | 10 | pulse2.com | ||
| STRYKER Aktie jetzt für 0€ handeln | |||||
| Mi | BMO senkt Kursziel für Stryker nach revidierten Schätzungen auf 317 $ | 45 | Investing.com Deutsch | ||
| Mi | BMO cuts Stryker stock price target on revised estimates to $317 | 9 | Investing.com | ||
| Mi | Wells Fargo cuts Stryker stock price target on revenue concerns | 19 | Investing.com | ||
| Di | Lieferkettenprobleme belasten Stryker: Aktie bricht um 7,7 % ein | 169 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
168 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 12:15 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| 12:15 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| 14:12 | Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors | GlobeNewswire (Europe) | Regulatory and quality expertise strengthens Board as Candel advances toward planned Biologics License Application (BLA) submission and potential commercial readiness NEEDHAM, Mass., Sept. 10, 2026... ► Artikel lesen | |
| 13:24 | Burning Rock Biotech Limited: Burning Rock Reports Second Quarter 2026 Financial Results | GlobeNewswire (Europe) | GUANGZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the "Company" or "Burning Rock"), a company focused on the application of next-generation sequencing... ► Artikel lesen | |
| 13:36 | CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026 | GlobeNewswire (Europe) | 12-week biomarker data to be highlighted at the International Society of Frontotemporal Dementias (ISFTD) Annual Meeting nfvPPA, the type of frontotemporal dementia (FTD) most commonly associated... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STRYKER CORPORATION finden Sie auf Wallstreet Online.